Aspirin's 'double hit' on bowel cancer
(Medical Xpress) -- Aspirin kills cancer cells by controlling two key processes that influence energy use in cells and could explain how aspirin can prevent bowel cancer. The research is published in this months Gastroenterology.
Cancer Research UK-funded scientists have found that aspirin switches off mTOR, a protein that is overactive in bowel cancer cells. mTOR plays a part in allowing cancer cells to produce excess proteins causing them to grow faster than they should.
At the same time, aspirin activates another protein, AMPK, which switches on pathways that generate energy but halts other processes in the cell that need energy, including mTOR.
In showing this double hit, the scientists, based at the University of Edinburgh and Dundee, have unveiled an important mechanism by which aspirin causes cancer cells to destroy themselves.
Researcher Dr. Farhat Din, a Cancer Research UK clinician scientist fellow at the University of Edinburgh, said: There is growing evidence showing that aspirin protects against cancer, but how it brings this about is the subject of much active research. Our new work shows, for the first time, that aspirin is acting on two master regulators of energy in bowel cancer cells and has given us a real insight to the disease.
mTOR acts in the cell as a central hub that monitors levels of nutrients. By studying cancer cell lines, mice and samples from patients, the researchers were able to show that aspirin was blocking mTOR by measuring levels of proteins that it controls.
There is a growing body of evidence that aspirin can help prevent several cancers, though we know that long term aspirin use can cause harm in some high risk groups.
The scientists ultimate aim is to identify targets in the processes involved in cell energy balance in order to develop new drugs that are even better and safer than aspirin at preventing bowel and other cancers.
Dr. Din added: Drugs that target mTOR have been hampered by the cancers ability to find alternative ways of using the same pathway, leaving these drugs useless. Using aspirin as a template, we hope to be able to develop drugs that target several parts of the same pathway, enabling us to get around this resistance.
Professor Nic Jones, Cancer Research UKs chief scientist, said: This fascinating research provides an invaluable insight into how aspirin is working in bowel cancer cells. It builds on this teams earlier work that was the first to demonstrate that aspirin worked to prevent bowel cancer. Cancer Research UK is funding trials and research to find out more about the role aspirin could have in preventing cancer.
We recommend that anyone considering taking aspirin for cancer prevention should discuss doing so with their GP.
More information: Din, F et al Aspirin Inhibits mTOR Signaling, Activates AMP-Activated Protein Kinase, and Induces Autophagy in Colorectal Cancer Cells Gastroenterology (2012)
Journal reference: Gastroenterology
Provided by Cancer Research UK
- Scientists prove regular aspirin intake halves cancer risk Oct 28, 2011 | not rated yet | 0
- Aspirin may lower the risk of pancreatic cancer Apr 04, 2011 | not rated yet | 0
- Aspirin may cut cancer deaths slightly Jun 07, 2007 | not rated yet | 0
- Scientists identify mechanisms in aspirin that help protect against cancer Jun 01, 2012 | not rated yet | 0
- Long-term use of adult-strength aspirin linked to a moderate decreased cancer risk Apr 18, 2007 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Pressure-volume curve: Elastic Recoil Pressure don't make sense
22 hours ago From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013 As an experiment, for the past few months I've been consuming at least one portion of Jell-O or unflavored Knox gelatin per day. I'm 64, in very...
Alcohol and acetaminophen
May 13, 2013 Edit: sorry for the typo in the title , can't edit I looked around on google quite a bit and it's very hard to find precise information on the...
Marie Curie's leukemia
May 13, 2013 Does anyone know what might be the cause of Marie Curie's cancer
- More from Physics Forums - Medical Sciences
More news stories
The use of a smartphone application significantly improves patients' preparation for a colonoscopy, according to new research presented today at Digestive Disease Week (DDW). The preparation process, which begins days in ...
Cancer 27 minutes ago | not rated yet | 0
Research presented at Digestive Disease Week (DDW) explores new methods for managing digestive health through diet and lifestyle.
Cancer 47 minutes ago | not rated yet | 0
A ground-breaking advance in colonoscopy technology signals the future of colorectal care, according to research presented today at Digestive Disease Week(DDW). Additional research focuses on optimizing the minimal withdrawal ...
Cancer 15 hours ago | 5 / 5 (2) | 0
(HealthDay)—Concurrent use of two immune checkpoint antibodies—ipilimumab and nivolumab—may be effective for the treatment of advanced melanoma, according to a proof-of-principal study presented in ...
Cancer May 17, 2013 | not rated yet | 0
(HealthDay)—The risks of metastasis and death associated with cutaneous squamous cell carcinoma (CSCC) are low, but significant, and risk factors for poor outcome include tumor diameter, invasion beyond ...
Cancer May 17, 2013 | not rated yet | 0 |
Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, Mayo Clinic research shows. The findings were being presented at the Digestive Disease ...
1 hour ago | not rated yet | 0 |
Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the ...
58 minutes ago | 4.5 / 5 (2) | 0 |
There are significant cost and risk factors associated with two procedures commonly used to diagnose or treat gastrointestinal problems, according to research presented at Digestive Disease Week (DDW).
37 minutes ago | not rated yet | 0
An increasing number of U.S. children are experiencing gastrointestinal issues that require interventions to resolve, according to research presented at Digestive Disease Week (DDW).
15 hours ago | not rated yet | 0 |
The latest makeover to a massive psychiatric tome honored by some, reviled by others and even called the "Bible" of mental disorders is being released Saturday with a host of new changes.
13 hours ago | not rated yet | 0